Collins Cooper C.

Chief Strategic Officer at PERNIX THERAPEUTICS HOLDINGS, INC.; Director at TXMD

Sold, on record
$21.8M
Dollars the filings state
Form 4 sales
12
Latest Apr 2, 2014
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Nov 5 2013

    Sold 90,000 shares at $2.00 ($180k)

    Collins Cooper C., Chief Strategic Officer

    Sold 1.4% of holdings ($13.1M position)6.5M shares leftFiling

  2. 2 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Dec 4 +29 days

    Sold 52,548 shares at $2.44 ($128k)

    Collins Cooper C., Chief Strategic Officer

    Sold 0.8% of holdings ($15.7M position)6.4M shares left0.8x usual sizeFiling

  3. 3 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Dec 6 +2 days

    Sold 37,452 shares at $2.31 ($87k)

    Collins Cooper C., Chief Strategic Officer

    Sold 0.6% of holdings ($14.8M position)6.4M shares left0.6x usual sizeFiling

  4. 4 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Jan 6 +31 days

    Sold 62,038 shares at $2.35 ($146k)

    Collins Cooper C., Chief Strategic Officer

    Sold 1% of holdings ($14.9M position)6.3M shares left1.2x usual sizeFiling

  5. 5 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Jan 7 +1 day

    Sold 27,962 shares at $2.20 ($62k)

    Collins Cooper C., Chief Strategic Officer

    Sold 0.4% of holdings ($13.9M position)6.3M shares left0.5x usual sizeFiling

  6. 6 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Feb 5 +29 days

    Sold 90,000 shares at $2.22 ($200k)

    Collins Cooper C., Chief Strategic Officer

    Sold 1.4% of holdings ($13.9M position)6.2M shares left1.7x usual sizeFiling

  7. Mar 4 +27 days

    Sold 3.6M shares at $3.41 ($12.2M)

    Collins Cooper C., Chief Strategic Officer

    Sold 58.1% of holdings ($21M position)2.6M shares left62.7x usual sizeFiling

  8. 8 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not stated
    Apr 2 +29 days

    Sold 90,000 shares at $5.26 ($473k)

    Collins Cooper C., Chief Strategic Officer

    Sold 3.5% of holdings ($13.6M position)2.5M shares left1.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Collins Cooper C.
Source
Apr 2, 2014PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale90,000$473k3.5%Plan not statedSEC
Mar 4, 2014PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale3.6M$12.2M58.1%UnusualSEC
Feb 5, 2014PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale90,000$200k1.4%Plan not statedSEC
Jan 7, 2014PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale27,962$62k0.4%Plan not statedSEC
Jan 6, 2014PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale62,038$146k1.0%Plan not statedSEC
Dec 6, 2013PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale37,452$87k0.6%Plan not statedSEC
Dec 4, 2013PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale52,548$128k0.8%Plan not statedSEC
Nov 5, 2013PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale90,000$180k1.4%Plan not statedSEC
Oct 8, 2013PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale23,364$58k0.4%Plan not statedSEC
Oct 3, 2013PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic OfficerForm 4 sale66,636$170k1.0%Plan not statedSEC
Jun 14, 2013TXMDDirectorForm 4 sale2.6M$4.6M100.0%UnusualSEC
Jul 21, 2011PERNIX THERAPEUTICS HOLDINGS, INC.President and CEOForm 4 sale498,429$3.5M5.3%Plan not statedSEC